Latest / Pharmacy Podcast Network / Reduce Inflammation with Science-Backed Natural Solutions with Samuel Shepherd - Part 1 | Holistic Pharmacy Podcast

Transcript

Reduce Inflammation with Science-Backed Natural Solutions with Samuel Shepherd - Part 1 | Holistic Pharmacy Podcast · Pharmacy Podcast Network

0:05
Speaker 1: You are listening to the global network of podcasters dedicated
0:09
Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
0:27
Speaker 2: Hello, and welcome to the Holistic Pharmacy Podcast. I'm your host,
0:33
Speaker 2: Marina books Of and I'm a functional medicine pharmacist in
0:36
Speaker 2: New York. I'm also a clinical herbalist and an integrative
0:40
Speaker 2: health coach specializing in mindfulness and empowerment. I'm on a
0:45
Speaker 2: mission to transform the way we approach healthcare by bridging
0:49
Speaker 2: the wisdom of traditional medicine with modern practice, and in
0:53
Speaker 2: this podcast, I will be highlighting guests who do just that.
0:58
Speaker 2: I'm constantly inspired by them and I know you will
1:01
Speaker 2: be as well.
1:06
Speaker 3: Hello everybody, Welcome back to the Holistic Pharmacy Podcast.
1:09
Speaker 4: I have another special guest for you today.
1:12
Speaker 3: His name is doctor Samuel Sheppard and he's an award
1:15
Speaker 3: winning physicist, inventor and engineer with forty two patents and
1:20
Speaker 3: over fifty years of breakthrough in medical, environmental and biochemical engineering.
1:27
Speaker 3: After overcoming a rare bone marrow cancer through his own innovation,
1:32
Speaker 3: he developed Velasta, the only patented glycosidic form of astax
1:37
Speaker 3: anthon designed to combat inflammation and restore vitality. Today, he's
1:42
Speaker 3: dedicated to educating others on natural solutions for aging with strength,
1:47
Speaker 3: energy and resilience.
1:49
Speaker 4: Without further ado, Samuel, welcome to the show.
1:52
Speaker 5: Thank you Marina for having me and this opportunity to
1:57
Speaker 5: get this message out.
2:00
Speaker 3: Absolutely, it's a very very impressive background, like a lot
2:03
Speaker 3: of the guests we have on the show here. So
2:06
Speaker 3: let's dive into the first question, which is really just
2:09
Speaker 3: sharing more about your background.
2:11
Speaker 4: Your beginning story. What kind of led you to choose
2:15
Speaker 4: a career.
2:16
Speaker 3: In such amazing feats with medical, environmental and biochemical engineering.
2:22
Speaker 5: Sure, my undergraduate degrees were in chemistry and physics. I
2:29
Speaker 5: have a bachelor's of science and chemical engineering and a
2:32
Speaker 5: master's in biochemical and environmental engineering. And then during COVID,
2:38
Speaker 5: I went back and got a doctorate in divinity. And
2:42
Speaker 5: that makes for a very interesting philosophical discussion between science
2:47
Speaker 5: and faith. And that was the reason I did it
2:50
Speaker 5: was I get into a lot of discussions with regards
2:54
Speaker 5: to the conflict between science and in faith. But that
3:03
Speaker 5: launched me into a career primarily in polymer science. I
3:08
Speaker 5: worked for Uni Carbide for a number of years in
3:10
Speaker 5: making plastics, polystyrene polysulfone bacylte, and then went to work
3:16
Speaker 5: for company Code Air Products, where we made polyvinyl chloride,
3:20
Speaker 5: and so I had a very strong background in reaction kinetics, polymers,
3:26
Speaker 5: and invariably the environmental side, because a lot of these
3:31
Speaker 5: chemical plants have real serious environmental concerns, and it seemed
3:35
Speaker 5: like it was always it was always the environmental group
3:38
Speaker 5: that stopped every project that I wanted to do in
3:41
Speaker 5: a chemical plant. So I wanted to know more and
3:43
Speaker 5: more about about that side of it. So I went
3:46
Speaker 5: back and got a master's in biochemistry and environmental science
3:50
Speaker 5: from Murray State University. I spent a lot of time
3:57
Speaker 5: on special projects. I worked on technologies around electromagnetic pulse
4:08
Speaker 5: weaponry auditory weaponry out of Brooks Air Force Base, and
4:14
Speaker 5: had spent a lot of time with that. I worked
4:16
Speaker 5: on the sterilization of bioslids or sludge coming out of
4:23
Speaker 5: a wastewater creatment plant. I built plants around the world.
4:28
Speaker 5: We put some facilities in in China for the two
4:31
Speaker 5: thousand and eight Olympics, put some plants in England, and
4:34
Speaker 5: I believe at this point we have somewhere around forty
4:37
Speaker 5: plants operating here in the US. But during the course
4:41
Speaker 5: of that process, in two thousand and three, I was
4:46
Speaker 5: having some blood pressure issues. Couldn't figure out what it was.
4:49
Speaker 5: I thought I had a fairly clean diet, and it
4:52
Speaker 5: turned out I had a blood bone marrow cancer called
4:57
Speaker 5: polypsythemia vira, and it was very unsettling because there was
5:03
Speaker 5: no chemo, no radiation treatments. The only way to keep
5:07
Speaker 5: me alive was to have me flebottomized, and I was
5:10
Speaker 5: flebotomized every month. And it's an interesting issue because it
5:18
Speaker 5: turned out the solution to my pollution was dilution. And
5:24
Speaker 5: what it was was they my red blood cells would
5:28
Speaker 5: accumulate to very high levels and it would increase my
5:33
Speaker 5: blood pressure, like pumping ketchup through your arteries. So the
5:39
Speaker 5: only way to keep the threat of stroke or thrombosis
5:43
Speaker 5: down was to take the blood out. So I did
5:47
Speaker 5: that for four years, every month for four years, and
5:51
Speaker 5: it was winning. I knew that I was losing this
5:54
Speaker 5: battle and my blood was getting thicker. I couldn't quite
6:02
Speaker 5: get it under control. The phlebotomies were going to have
6:05
Speaker 5: to increase, and I knew that I was probably going
6:09
Speaker 5: to end up with a stroke or a heart attack,
6:11
Speaker 5: or a blood clot in the lung of some form
6:15
Speaker 5: or fashion. So it became very concerning to me knowing
6:21
Speaker 5: that this was terminal and that I probably wasn't going
6:24
Speaker 5: to get out of here in very good shape. So
6:31
Speaker 5: God and I got really close at that point, and
6:36
Speaker 5: I spent a lot of time at four o'clock in
6:38
Speaker 5: the morning trying to figure out what was the purpose
6:41
Speaker 5: of life? Why was I led down this path? And
6:45
Speaker 5: they're just thoughts that when we talk to people who
6:48
Speaker 5: are faced with cancer, they have a lot of the
6:50
Speaker 5: same thoughts the inevitability of or the purpose of our lives.
6:57
Speaker 5: And it truly came to me one more warning that
7:01
Speaker 5: there's got to be some animals or plants or something
7:03
Speaker 5: on this planet that doesn't get cancer. And God had
7:08
Speaker 5: blessed me with a lot of tools for the toolbox,
7:11
Speaker 5: and I could figure out most things. I worked on
7:14
Speaker 5: the Lunar Outpost Commission on Going from Earth to Moon
7:19
Speaker 5: to Mars nineteen ninety one to nineteen ninety four. I
7:24
Speaker 5: had spent a lot of time in the development of
7:26
Speaker 5: ballistic weapons, lethal and non lethal weaponry, and bioweapons design.
7:31
Speaker 5: I am a diplomat of the Forensic Board of American Examiners,
7:42
Speaker 5: and so I had a lot of I had a
7:46
Speaker 5: lot of skills that I was blessed with. So when
7:51
Speaker 5: I was diagnosed with cancer, I figured that if this
7:54
Speaker 5: could be figured out from a biochemical point of view
7:58
Speaker 5: and from a scientific point of view, I could figure
8:01
Speaker 5: this out. So in must have been about two thousand
8:07
Speaker 5: and six, I guess two thousand and seven, I went
8:13
Speaker 5: to I was working on a project for the Department
8:15
Speaker 5: of Defense in San Diego. Had access to a database
8:19
Speaker 5: called ProQuest. So I queried that database and wanted to
8:23
Speaker 5: know all the animals and plants that don't get cancer,
8:26
Speaker 5: no recorded cases of cancer. And it came back that
8:30
Speaker 5: there were five animals salmon, pink flamingos, sharks, elephants, and
8:36
Speaker 5: naked morats. So I had inquired as to how to
8:43
Speaker 5: do a mass spec of those tissue samples and to
8:47
Speaker 5: see what was different, and the screening algorithm was. I
8:53
Speaker 5: wanted to screen out proteins, carbohydrates, lipids, enzymes, rotenoids that
9:00
Speaker 5: were typically produced by the organism itself. And I wanted
9:04
Speaker 5: to find the molecules that were found in all five
9:09
Speaker 5: of those species but is not produced by any of them,
9:15
Speaker 5: and Script's Oceanographic had done a lot of work on
9:18
Speaker 5: this also, So what came back was that there essentially
9:23
Speaker 5: was one that was found in all five of those species,
9:27
Speaker 5: and that was astes Anton. And at that point I began.
9:32
Speaker 5: I went to the University of Texas, got the Astes
9:34
Speaker 5: Anton algo species, began growing at my backyard, and one
9:38
Speaker 5: of those I call them Hillbilly hot tubs, but it's
9:40
Speaker 5: the intex hot tub that it blows up and you
9:44
Speaker 5: can put it in your backyard. Well, I created an
9:45
Speaker 5: algae reactor out of that. I began growing the algae
9:49
Speaker 5: and I got very very good at growing that algae,
9:54
Speaker 5: and I would harvest the algae, dehydrate it, and I
9:58
Speaker 5: knew it was three point eight percent Esta's anton, and
10:01
Speaker 5: I would put it in my eggs or in my
10:03
Speaker 5: food or salads at a specific dose level. So I
10:07
Speaker 5: started out at four milligrams per day equivalent of the
10:11
Speaker 5: biomass and my phlebotomies. Statistically it wasn't significant, but I
10:18
Speaker 5: wanted to make sure, because I'm eating a red algae
10:22
Speaker 5: that's usually a sign of toxicity, that it wasn't killing
10:25
Speaker 5: my liver, my kidneys, and I wasn't going to have
10:27
Speaker 5: a premature death from eating this algae. So I started
10:31
Speaker 5: at four milligrams and my phlebotomy has got pushed out.
10:35
Speaker 5: The slope changed, so from day one in the month
10:39
Speaker 5: to day thirty, my hemoglobein would climb out and I
10:43
Speaker 5: could actually plot it well. And that's what caused me
10:48
Speaker 5: to trigger to go get a phlebotomy was when it
10:50
Speaker 5: reached a certain level. Then at four milligrams, I noticed
10:55
Speaker 5: that it was I didn't have to get phlebotomized for
10:58
Speaker 5: two months every two month months. Statistically, it probably wasn't
11:04
Speaker 5: all that important, but at least it wasn't killing me.
11:08
Speaker 5: So I thought, okay, my blood work looks really good.
11:12
Speaker 5: I was actually running an A one C of about
11:14
Speaker 5: six point two, which was pre diabetic, and my A
11:18
Speaker 5: one c dropped down to five point four and I
11:21
Speaker 5: didn't change anything. So I knew that this had an
11:24
Speaker 5: overall health benefit to it, and the slope of the
11:28
Speaker 5: curve changed a little. So then I said, okay, let's
11:32
Speaker 5: just triple the dough Since it's not killing my liver
11:34
Speaker 5: or my kidneys, let's just go to twelve miligrams per day.
11:38
Speaker 5: So I went to twelve, and my phlebotomy has got
11:41
Speaker 5: pushed out to once every four months. That was significant
11:47
Speaker 5: after four to five years of being flebottomized every month,
11:50
Speaker 5: all of a sudden, now I'm flebottomized three maybe four
11:54
Speaker 5: times a year, and that was a game changer. I spent.
12:01
Speaker 5: I had some family members who were in stage four cancer.
12:05
Speaker 5: They knew that I was working on this project. I
12:08
Speaker 5: had moved from Texas to South Carolina. A group of
12:11
Speaker 5: investors asked me to come over to a secure location
12:15
Speaker 5: at the Navy Yard in Charleston. Moved there. We built
12:19
Speaker 5: these reactors. We began producing Asta's anthon, and I began
12:27
Speaker 5: I was still taking it at the time, and then
12:30
Speaker 5: my family members who had stage four cancer, they were
12:33
Speaker 5: sent home with hospice at two to four months three
12:36
Speaker 5: to six less than a year to live. So I
12:40
Speaker 5: began giving it to them at no charge, and their
12:44
Speaker 5: cancers went away. And some of the stories are huge
12:48
Speaker 5: where I had eight people in eastern Ohio on it,
12:53
Speaker 5: and the oncologist from the oncology Ohio Valley Medical called
12:59
Speaker 5: me and said, I have eight members here, there's stage four.
13:02
Speaker 5: There's nothing we can do for them. They've been home
13:04
Speaker 5: with hospice. Now they come in and they have no
13:08
Speaker 5: traces of cancer, and they don't know each other, but
13:12
Speaker 5: they've been taking this product called Velasta. Can you explain
13:17
Speaker 5: to me what this is? And I said, sure so,
13:21
Speaker 5: and she'd never heard of it before, and she ended
13:25
Speaker 5: up telling me that she wanted a little more information
13:28
Speaker 5: on it for personal reasons. And I said, oh, I said,
13:31
Speaker 5: I said, deserve is there's something going on and she said,
13:34
Speaker 5: not with me, but my husband was diagnosed with stage
13:37
Speaker 5: four prostate cancer and I said, well, her first name
13:42
Speaker 5: was Trish. I said, well, Trish, I said, you understand
13:45
Speaker 5: that you're an oncologist. You have a bunch of tools
13:48
Speaker 5: in your toolbox to treat him with surgery, chemical castration, radiology, chemotherapy.
13:56
Speaker 5: And her comment rattled me. She fired by she said,
14:00
Speaker 5: nobody in my family's doing chemo radiation. Now that's her
14:06
Speaker 5: basis of her entire livelihood. And I said, do you
14:11
Speaker 5: understand what you just said to me? She said, I
14:13
Speaker 5: understand perfectly well. She said it's the only protocol we have,
14:18
Speaker 5: and so I ended up sending her the product for
14:22
Speaker 5: her husband, and his PSA dropped from mid twenties down
14:29
Speaker 5: to under three in less than thirty days, and today,
14:33
Speaker 5: as far as I know, he's had no other treatment.
14:36
Speaker 5: We now have over three thousand cancer cases and they've
14:42
Speaker 5: all been either put into remission or no trace, to
14:46
Speaker 5: the point that doctors now are faced with a dilemma
14:49
Speaker 5: as to what is really going on, and they still
14:51
Speaker 5: won't admit that this product has any impact at all.
14:55
Speaker 5: And it has a tremendous impact. So we began to
15:00
Speaker 5: give it to people with cancer. We had one lady
15:03
Speaker 5: in Hershey, Pennsylvania, that we had given it to her
15:09
Speaker 5: for arthritis. She had severe arthritis, and in about ten
15:15
Speaker 5: days her pain all went away. This is this is
15:19
Speaker 5: not something you wait on. You don't have to wait
15:21
Speaker 5: on this to work. And in about ten days she
15:25
Speaker 5: called us back and my wife and I, excuse me.
15:29
Speaker 5: We're in the in the vehicle coming back from Virginia,
15:32
Speaker 5: and I had her on the on the car phone
15:36
Speaker 5: and she just wanted to thank me for this product
15:39
Speaker 5: because it helped her so much with arthritis. And she said, well,
15:43
Speaker 5: something you don't know is that I had severe Parkinson's.
15:48
Speaker 5: She said, I couldn't even hold food on my fork,
15:50
Speaker 5: my tremors were so bad. And she said I was
15:54
Speaker 5: being treated at Hershe Medical and they couldn't get my
15:58
Speaker 5: Parkinson's under control. She's said, I no longer have tremors.
16:02
Speaker 5: She said, I've gone in. The doctor was shocked. So
16:09
Speaker 5: so that sent me down another path to figure out
16:12
Speaker 5: how does this work from a chemical point of view,
16:16
Speaker 5: And it turns out we've got Parkinson's wrong. We believe
16:19
Speaker 5: that Parkinson's is caused by lack of dopamine being produced
16:22
Speaker 5: in the substantia neigro part of the brain. Turns out
16:26
Speaker 5: that's not true. When we looked at it, we still
16:29
Speaker 5: found huge amounts of dopamine being produced. But there's another
16:34
Speaker 5: chemical compound called hydroxy dopamine. Hydroxy dopamine is what we
16:41
Speaker 5: give to animals to simulate Parkinson's in animals so we
16:45
Speaker 5: can test medications on them. So here it's being produced
16:49
Speaker 5: in these Parkinson's patients. Now the chemistry, this is the
16:55
Speaker 5: difference between the medical application of treatments versus the scientific
17:03
Speaker 5: side of treatments, because medical and science are not always
17:07
Speaker 5: in line. So medically, in the chemical equation, we have
17:12
Speaker 5: dopamine plus the hydroxyl free radical OH. Free radical yields
17:19
Speaker 5: hydroxy dopamine. So the higher the hydroxyl free radical is
17:25
Speaker 5: in your body, the more likely it is to react
17:28
Speaker 5: with the dopamine to give you the Parkinson's inducing molecule
17:34
Speaker 5: that causes Parkinson's. Well's what the medical department deals with
17:39
Speaker 5: is they want to sell you more dopamine synthetics leve
17:43
Speaker 5: a dopa carbon dopa, so they focus on the dopamine,
17:47
Speaker 5: the lack of dopamine, so they give you more dopamine,
17:52
Speaker 5: but they're not controlling the hydroxyl free radical. So the
17:57
Speaker 5: increase in dopamine level, we're for a short period of
18:01
Speaker 5: time until your hydroxyl free radical inventory begins to increase.
18:07
Speaker 5: It reacts with the dopamine and actually exacerbates your Parkinson's
18:11
Speaker 5: by increasing more hydroxy dopamine. I hope that makes sense,
18:15
Speaker 5: but that's what is causing Parkinson's, So we focused on
18:20
Speaker 5: the elimination of the hydroxyl free radical. Makes perfect scientific sense.
18:25
Speaker 5: That's the limiting reactant. So let the brain produce all
18:30
Speaker 5: of the dopamine. We just take away the other reactant,
18:35
Speaker 5: the hydroxy free radical, so we don't generate any hydroxy dopamine.
18:39
Speaker 5: And it works. The Velasta works so well because it's
18:45
Speaker 5: a glucosidic form. So we attach a glucose molecule to
18:51
Speaker 5: the astaxanthin, and when we do that, the absorption goes
18:57
Speaker 5: up by a factor of eight in the small vowel.
19:00
Speaker 5: So taking regular astes anthon or pure astes anton is
19:03
Speaker 5: very difficult to absorb. It's usually flushed out, but with
19:08
Speaker 5: a glucosidic form, it's called a trojan horse. And this
19:13
Speaker 5: technology or organic chemistry I learned when we make bio weapons.
19:17
Speaker 5: If you want to buy a weapon to go in
19:20
Speaker 5: on a time dependent so you rub somebody on the
19:24
Speaker 5: arm with a molecule, three days later he dies, you're
19:28
Speaker 5: out of the country. There's a lot of reasons why
19:30
Speaker 5: those weapons were being developed that way. Well, I used
19:33
Speaker 5: similar I want it absorbed into the body and stored
19:39
Speaker 5: in the body. So when we put the glucose on it,
19:42
Speaker 5: now it's readily absorbed at very high rates. And the
19:45
Speaker 5: astes anton the way this works and cancer cells, cancer
19:51
Speaker 5: cells consume a lot of sugar. That's primarily the food
19:56
Speaker 5: material for cancer cells. The Warburg effect shows that cancer
20:01
Speaker 5: lives in somewhat of an acidic environment. Where it gets
20:05
Speaker 5: its acidity from is the oh molecules that's on the
20:09
Speaker 5: sugar that's being metabolized by the cancer. It's spun out
20:13
Speaker 5: of the mitochondria as a free radical an OH with
20:17
Speaker 5: a zero charge. What that means is that it's it's
20:21
Speaker 5: highly reactive. It's wanting to pair one of the vacant
20:25
Speaker 5: valence shells and it will steal an electron from something
20:31
Speaker 5: well that's basically a Lewis acid. So around the cancer cell,
20:39
Speaker 5: the pH is about five point two. Seven is neutral,
20:42
Speaker 5: anything below seven is acidic, anything above seven is alkaline.
20:48
Speaker 5: So around the cancer cell, it's producing an acidic environment
20:53
Speaker 5: of about five point two and it kills adjacent cells.
20:56
Speaker 5: And that's how cancer makes room for the tumor to
20:59
Speaker 5: grow by killing your normal cells that can't live in
21:04
Speaker 5: that type of an acidic environment. But we have these
21:08
Speaker 5: oh's zero charge. Now, when the cancer cell sees that
21:13
Speaker 5: glucose attached to the astes antin, it sucks it in.
21:17
Speaker 5: It wants that sugar. Once inside, the cancer cleaves the
21:22
Speaker 5: glucose off of the astes anton, leaving the astes anton
21:25
Speaker 5: inside the cell. In prost cellular it uses the glucose
21:29
Speaker 5: for energy. Now the astes anton is inside the cell
21:34
Speaker 5: and the astesantin can donate an electron without itself becoming
21:39
Speaker 5: a free radical. That's the advantage of this. So when
21:43
Speaker 5: it donates an electron minus one little electron to an
21:48
Speaker 5: OH zero charge, it becomes an OH minus one. Now
21:55
Speaker 5: that converts the hydroxyl free radical into a hydroxyl ion.
22:01
Speaker 5: That OH minus one shoots the pH up over twelve.
22:05
Speaker 5: The Warburg effect kicks in. The cancer cell dies within
22:08
Speaker 5: four seconds. That's how it works. Warburg had it figured
22:16
Speaker 5: out that alkalinity causes cancer cells to die. But it's
22:24
Speaker 5: very difficult to get alkalinity patched and through your blood
22:28
Speaker 5: because blood pH is always, always, can never change seven
22:32
Speaker 5: point three five to seven point three eight. It's tightly controlled,
22:37
Speaker 5: so you cannot eat alkaline foods. You can't take baking soda,
22:41
Speaker 5: for example, and expect it to get to your cancer
22:44
Speaker 5: cell because it can't get through your blood barrier. Your
22:48
Speaker 5: blood barrier can never change, so it's always seven point
22:51
Speaker 5: thirty five. Now, the way we trick this is that
22:56
Speaker 5: change doesn't happen until it's already delivered to the cell.
23:00
Speaker 5: So the ascdxanthine is readily absorbed by the blood stream
23:04
Speaker 5: doesn't affect the pH of the bloodstream gets into the
23:07
Speaker 5: cancer cell and immediately changes the pH of the cancer cell,
23:11
Speaker 5: causing apoptosis or subpontification of the cell membrane, the phospholipid membrane.
23:18
Speaker 5: That's how we make soap. When we take fatty acids
23:22
Speaker 5: and we mix it with sodium hydroxide, that's how we
23:27
Speaker 5: make lie or soap. Well, that happens at the cell
23:30
Speaker 5: membrane of a cancer cell. That is a fatty acid
23:34
Speaker 5: phospholipid membrane, and as soon as you run the pH alkalin,
23:39
Speaker 5: it sepontifies that cell membrane. The membrane bursts open, and
23:43
Speaker 5: all of the guts of the cancer cell flood flood out,
23:45
Speaker 5: and the cell dies. That's how it works. That's a
23:51
Speaker 5: lot of information, and it's a lot of years of
23:53
Speaker 5: research all compiled into that little little dissertation. But if
23:58
Speaker 5: you've got any questions, feel free to ask.
24:01
Speaker 3: My goodness, yes I have a lot of questions. I'm
24:05
Speaker 3: over here taking notes. I'm sure a lot of the
24:08
Speaker 3: listeners are pausing and rewinding and also going back because
24:12
Speaker 3: there's a lot of gems right there with the mechanism
24:15
Speaker 3: of action that you just dropped.
24:18
Speaker 4: And this is very, very impressive. I'll just say that.
24:23
Speaker 3: So my like initial questions are is this being studied
24:29
Speaker 3: in the literature, are there ongoing studies because you mentioned
24:34
Speaker 3: you know, the medical community's interest in it, but also
24:36
Speaker 3: a little bit of dismissal. It sounds like on the
24:39
Speaker 3: scientific level and legally and politically speaking, there seem to
24:45
Speaker 3: be a lot of rumors and conspiracy theories about the
24:49
Speaker 3: cancer industry, like suppressing natural treatment options.
24:54
Speaker 4: So what's been your experience with your I'm.
24:57
Speaker 5: Very familiar with the way it works. Sologists are the
25:01
Speaker 5: only doctors that get paid cash for putting people on
25:04
Speaker 5: chemo and on radiation. That's a documented fact. It's called
25:07
Speaker 5: remuneration bias. Only about two thirds of all PET scans
25:13
Speaker 5: showing positive are actually cancer. Scans cannot differentiate between inflammation
25:21
Speaker 5: and cancer, so there's a lot of false positives that's
25:28
Speaker 5: coming out of the scanning operation. But if an oncologist
25:31
Speaker 5: reads that PET scan one hundred percent of the time,
25:34
Speaker 5: it is always cancer. The best way to figure it
25:37
Speaker 5: out is through a biopsy, where you can actually look
25:39
Speaker 5: at the cells and determine whether they are in fact
25:42
Speaker 5: mutated cancer cells or not. The remuneration bias is pretty
25:50
Speaker 5: important because oncologists get paid cash from the pharmaceutical companies
25:55
Speaker 5: and also from the insurance companies. That is documented fact,
26:00
Speaker 5: it's not conspiracy theory. They're the only doctors that can
26:04
Speaker 5: and when they technically will buy the chemo drugs from
26:09
Speaker 5: the pharmaceutical company at a huge discount, and then they
26:14
Speaker 5: up charge and the insurance company pays them the margin.
26:20
Speaker 5: That's how it works, and they want to get as
26:23
Speaker 5: many people on chemo or radiation as they possibly can.
26:27
Speaker 5: Each patient to an oncologist in the long run is
26:30
Speaker 5: about a quarter of a million dollars into his bank account.
26:36
Speaker 5: That's a fact. I'm not going to get into the
26:38
Speaker 5: politics or what's true and what isn't what's but morally
26:43
Speaker 5: and ethically, what I've just told you is absolute truth.
26:47
Speaker 4: Yeah.
26:48
Speaker 3: Yeah, that makes sense with the model and the flaws
26:50
Speaker 3: that you just outlined. So when you discovered this, as
26:56
Speaker 3: does Anthem, with the technology and the delivery system that
26:59
Speaker 3: you just outlined as well, what was your experience legally
27:05
Speaker 3: like navigating getting this product out to patients, right? Because
27:09
Speaker 3: did you have to make a patent, did you have
27:11
Speaker 3: to get it registered as a supplement like, what was
27:14
Speaker 3: your process and how do you feel maybe the politics
27:18
Speaker 3: either worked against you or what was its role in
27:22
Speaker 3: the process.
27:23
Speaker 5: I was put in a very very interesting position as
27:27
Speaker 5: being a researcher. So my research is covered under the
27:30
Speaker 5: First Amendment, under the Freedom of Information Act, and if
27:34
Speaker 5: you read that, it says no government official can interfere
27:38
Speaker 5: with my ability to do research. Not the FDA, not
27:42
Speaker 5: the US government, not any employees, not the Department of
27:47
Speaker 5: Health and Human Services, not the NIH, not the CDC,
27:51
Speaker 5: no government official. And me being a researcher allowed me
27:57
Speaker 5: to operate under the First Amendment. And I've had some
28:03
Speaker 5: cases or complaints filed against me for practicing medicine because
28:07
Speaker 5: I'm not a prescribing doctor, and I end up winning
28:10
Speaker 5: those cases, and I won them under the First Amendment
28:14
Speaker 5: right in that I could individually sue the Director of
28:18
Speaker 5: Health and Human Services for her interference with me as
28:24
Speaker 5: a researcher, interfering with my right to do research, and
28:29
Speaker 5: they shut it down quick. They wanted out as fast
28:32
Speaker 5: as they could. So that's the key. Now, doctors are
28:37
Speaker 5: held to a different standard because that's their profession. So
28:43
Speaker 5: in my case, when I began to look at it
28:46
Speaker 5: I filed the patent and the title of the patent
28:49
Speaker 5: is a method for the process of using astesanthon for
28:55
Speaker 5: the treatment of inflammatory disease treatment of inflammatory disease, particularly
29:04
Speaker 5: for the treatment of cancer. That was unheard of in
29:08
Speaker 5: the supplement industry, and yet the Patent Office allow it.
29:12
Speaker 5: So now we have a little bit of a dilemma.
29:14
Speaker 5: The Patent Office requires that I use that title when
29:18
Speaker 5: I when I issue the patent number on our documents,
29:21
Speaker 5: it says this product can be used to treat inflammatory disease,
29:24
Speaker 5: treat and it can be used to treat cancer. The
29:30
Speaker 5: labeling requirements under OCEAN under the FDA say that this
29:33
Speaker 5: product cannot be used to treat, diagnose, or cure any disease.
29:38
Speaker 5: So we have two government agencies in conflict. We've gotten
29:43
Speaker 5: no pushback from that. We might after this podcast, but
29:47
Speaker 5: we haven't today gotten any pushback. So they recognize the
29:55
Speaker 5: fact that this it's a story that I want to
30:04
Speaker 5: tell to a jury and I'm hoping that somebody wants
30:10
Speaker 5: to file a lawsuit and let's go resolve this one
30:16
Speaker 5: way or another. Because what the NIH, the CDC, the
30:20
Speaker 5: FDA have all done is ethically immoral. And now is
30:25
Speaker 5: a good time to do that because some of what
30:28
Speaker 5: Robert Kennedy has done has shown the immorality of what
30:33
Speaker 5: our health program has tried to sell to us, and
30:39
Speaker 5: it is unethical and it's something that the people need
30:46
Speaker 5: to know what's going on. We have a scientific basis.
30:49
Speaker 5: There's over a thousand peer reviewed articles now from the
30:52
Speaker 5: NIH showing that astes antone has this effect. In twenty nineteen,
31:01
Speaker 5: just to give you an example, April twenty nineteen, I
31:03
Speaker 5: was asked to go to Washington and speak and I
31:06
Speaker 5: spoke for two hours to a bunch of senators, representatives, businessmen.
31:11
Speaker 5: There were five major hospitals there, John Hopkins, m D Anderson, Mayo,
31:15
Speaker 5: and the Cleveland Clinic were all in attendance. And I
31:19
Speaker 5: told them that we now know what causes disease. About
31:22
Speaker 5: ninety two percent of all all diseases are inflammatory and
31:26
Speaker 5: those diseases can now be prevented. Well, that sent ripples
31:31
Speaker 5: through because if you all of a sudden can stop disease,
31:35
Speaker 5: the entire medical department industry collapses. And that sent ripples.
31:43
Speaker 5: So I went through a legal complaint in July of
31:47
Speaker 5: twenty nineteen, end up winning that case had a complaint
31:51
Speaker 5: filed in Texas. I won that case. Then in November,
31:59
Speaker 5: the end end of November early December of twenty nineteen,
32:04
Speaker 5: I was hanging Christmas lights in my front yard and
32:06
Speaker 5: somebody tried to take me out. Put a bullet through
32:09
Speaker 5: my fence, missed me by four inches, and I jumped
32:14
Speaker 5: behind a truck, yelled up, there's just woods on the
32:16
Speaker 5: other side of where I live, and told him to
32:19
Speaker 5: stop shooting. Didn't hear anything back. I still have the
32:23
Speaker 5: bullet hole in the fence. I can send you a
32:24
Speaker 5: picture of that. I called the sheriff. Sheriff came out,
32:30
Speaker 5: drew his weapon, walked up in there, saw where somebody
32:32
Speaker 5: had powered up leaves and had been laying in the
32:35
Speaker 5: leaves for a fairly lengthy period of time. And I
32:41
Speaker 5: got involved with giving the statement explaining what I do
32:47
Speaker 5: and what I was entering into, and he filed to
32:53
Speaker 5: complaint with the FBI, and the FBI gave me the
32:57
Speaker 5: best advice. They said, it's bad for business, but you've
33:01
Speaker 5: got to go tell everyone exactly what you have. You've
33:06
Speaker 5: got to go public with this, so there's no incentive
33:10
Speaker 5: for taking me out. Now. The gig's up. We now
33:13
Speaker 5: know what the doctors are treating. We now know how
33:17
Speaker 5: to prevent people from getting these diseases. And this is
33:21
Speaker 5: the key. And my harassment has stopped. I haven't now
33:27
Speaker 5: after this podcast it might pick up again, but we'll see.
33:32
Speaker 5: But at my age, there's no more fear in my life.
33:37
Speaker 5: I died in two thousand and three. I went through
33:40
Speaker 5: all the stages of dying and was on the acceptance
33:43
Speaker 5: side of that cage, and God gave me an extension.
33:52
Speaker 5: So there's really nothing to fear anymore, especially if it's
33:55
Speaker 5: the truth and it's a good story to tell to
33:58
Speaker 5: a jury that they are being used to some extent,
34:03
Speaker 5: those doctors work for the patient, and yet those doctors
34:07
Speaker 5: believe because if you come in and say I don't
34:09
Speaker 5: want to do chemo, they'll throw you out of the
34:11
Speaker 5: office because you're no longer a money source for them
34:16
Speaker 5: and they want and I've had people say this, somebody
34:20
Speaker 5: else will step into that person's shoes that is willing
34:23
Speaker 5: to put money in the doctor's bank account. And if
34:27
Speaker 5: you're not doing chemo and you're still seeing that doctor,
34:30
Speaker 5: there's no financial incentive for that doctor to keep you.
34:35
Speaker 5: It's a sad state of Affairs as to where our
34:37
Speaker 5: health program is now. It's got to stop, and the
34:43
Speaker 5: best way that I know to do it is to
34:45
Speaker 5: prevent disease. Let's stop this from happening.
34:52
Speaker 4: Wow.
34:53
Speaker 3: I completely agree and really respect that you're taking a
34:59
Speaker 3: stand on this and going public and sharing it on
35:02
Speaker 3: podcasts such as this.
35:03
Speaker 4: And I know my listeners are.
35:06
Speaker 3: Also probably intrigued and openly asking questions. If they haven't
35:13
Speaker 3: made up their mind yet, at least they are asking
35:17
Speaker 3: and inquiring is this the best way? Is this system
35:20
Speaker 3: really serving the way that it's intended to do no
35:25
Speaker 3: harm and provide service like treatment and curing that they are.
35:30
Speaker 4: Allowed to say, right?
35:32
Speaker 3: And if what's the cost of participating in a system
35:37
Speaker 3: as a healthcare provider that.
35:41
Speaker 4: Does a disservice instead of a service? So I really
35:44
Speaker 4: really appreciate you.
35:47
Speaker 3: Having this journey and having the courage to share it
35:50
Speaker 3: and continue doing this really really important work. And I
35:54
Speaker 3: have a lot more questions for you, but let's just
35:57
Speaker 3: start with how can we do this information and also
36:02
Speaker 3: this product to more people? Like what has been your
36:05
Speaker 3: process to promote it despite these challenges?
36:08
Speaker 5: Yeah, we'd looked at it from very early on, not
36:11
Speaker 5: secondarily selling a product. It was a huge educational component,
36:16
Speaker 5: and you're part of that element, by the way, because
36:19
Speaker 5: we've got to get word out to these people that
36:21
Speaker 5: there's hope, there's another option, there's something else that they
36:25
Speaker 5: can consider as to why they're sick. So basic protocol
36:30
Speaker 5: is the first thing that anyone should run is a
36:35
Speaker 5: blood test called an HSCRP. It stands for high sensitivity
36:41
Speaker 5: see reactive protein. Your doctor's going to question you as
36:47
Speaker 5: to why you even know about that test, and they
36:52
Speaker 5: all you have to do is say it's a measure
36:54
Speaker 5: of your chronic inflammatory disease state. That's what that measures.
37:01
Speaker 5: Some doctors are saying I won't run it, I will
37:05
Speaker 5: not include it on your bloodwork because insurance won't pay
37:08
Speaker 5: for it. Well, that's a flat out lie. Insurance will
37:11
Speaker 5: pay for it, they but they can't cret when that
37:15
Speaker 5: number comes back high greater than three milligrams per leter.
37:20
Speaker 5: Doctors are not in a position to prescribe a drug
37:23
Speaker 5: to reduce it, so they don't have a treatment option
37:28
Speaker 5: that is acceptable in the medical protocols to treat for
37:32
Speaker 5: chronic inflammatory disease. It is the chronic inflammatory disease that
37:38
Speaker 5: causes arthritis, type two diabetes, irritable bow diverticulitis, Alzheimer's, Parkinson's MS, cancer,
37:48
Speaker 5: heart disease. I have world renowned cardiologists who I could
37:56
Speaker 5: probably get you plugged into that are now prescribing it
37:59
Speaker 5: to all their cardio patients, and the results that he's
38:02
Speaker 5: seeing is amazing. No more plaque formation. It's not high
38:07
Speaker 5: cholesterol that causes disease. Cholesterol does not cause heart disease.
38:18
Speaker 5: The platformation is an effect of arterial inflammation caused by
38:24
Speaker 5: four one or more of four free radicals. There's the superoxide,
38:31
Speaker 5: the singlet oxygen, the peroxyl, and the hydroxyl free radical.
38:36
Speaker 5: I promise there won't be a test or won't have
38:37
Speaker 5: to answer any questions here, but those four free radicals
38:40
Speaker 5: cause ninety two percent of all human death, and we
38:45
Speaker 5: can measure the concentration of those in your body through
38:48
Speaker 5: the HSCRP test. So when that number comes back greater
38:53
Speaker 5: than three, you are now in line to get an
38:58
Speaker 5: inflammatory disease presents differently in different people. Some people get
39:02
Speaker 5: heart disease, some people get Alzheimer's, some people get irritable
39:06
Speaker 5: bow arthritis in the joints type two diabetes. It does
39:10
Speaker 5: not work on type one diabetes, so everybody sort of
39:17
Speaker 5: presents differently. But like the lady in Pennsylvania who we
39:20
Speaker 5: were treating for arthritis and it stopped for Parkinson's tremors, Well,
39:26
Speaker 5: it's the same thing that's causing both. It's just how
39:30
Speaker 5: it manifests itself in the symptoms of the disease. So
39:37
Speaker 5: it's fairly we've tried to compile it without getting into
39:44
Speaker 5: the chemistry of why it works. What are the twenty
39:46
Speaker 5: seven pathways of human disease in which one of those
39:50
Speaker 5: are I'm trying to simplify it to a single point
39:54
Speaker 5: where you measure your HSCRP. If it's greater than three,
39:59
Speaker 5: you are going want to get a disease. It's just
40:01
Speaker 5: a matter of time, and we want to knock that
40:04
Speaker 5: number under three. If I get that number under three,
40:06
Speaker 5: you will not get cancer, you will not get a
40:09
Speaker 5: heart disease, you won't have arthritis. Your inflammatory disease state
40:13
Speaker 5: is under control. But that's the key. Now, why does
40:21
Speaker 5: it seem to happen as we get older. Well, one
40:25
Speaker 5: of the studies that we did and I published was
40:29
Speaker 5: when we're young, we can do a lot of stupid things.
40:33
Speaker 5: I could drink a lot of beer. I could stay
40:35
Speaker 5: up late, I could eat pizza. I could spend hours
40:40
Speaker 5: chasing women and going through all the drama of life.
40:44
Speaker 5: I could do that and not get a disease. I
40:48
Speaker 5: was okay. And the reason is is young people typically
40:53
Speaker 5: are producing internal antioxidants called glutathione, superoxide, dismute, and catase.
41:01
Speaker 5: Those are the three that protect us as antioxidants during
41:06
Speaker 5: our child rearing periods. In men after the age of
41:11
Speaker 5: fifty and women after age forty two, on average, nature
41:16
Speaker 5: cuts off our ability to produce cellular glue to thione
41:22
Speaker 5: and it reduces our cellular antioxidant protective device. It's nature's
41:28
Speaker 5: way of taking us out. And as the glue thione
41:32
Speaker 5: level drops. And what we did is I measured the
41:36
Speaker 5: glue thione level in the blood system and the HSCRP,
41:41
Speaker 5: and I found the HSCRP is very low in young people.
41:44
Speaker 5: This is from age five to one hundred and five.
41:47
Speaker 5: I pull blood samples. So in the very young they
41:51
Speaker 5: are producing high levels of glue to thione, they're inflammatory
41:55
Speaker 5: disease markers very low. In women, the glue thione level
42:01
Speaker 5: drop off and the hsc r P level begins to
42:04
Speaker 5: take off. Now you're going to have you're going to
42:07
Speaker 5: go through your change of life. You're going to have stress,
42:12
Speaker 5: you're going to have arthritis, you're going to retain water.
42:15
Speaker 5: It's all inflammatory. And when we look at how do
42:23
Speaker 5: we replace the glue to thione, the only way you
42:26
Speaker 5: can't take glue to thione orally. It will never make
42:29
Speaker 5: it to the blood to the cell. It won't make
42:32
Speaker 5: it actually through the through the blood system, through the
42:35
Speaker 5: absorption from the small valle into the bloodstream and carried
42:37
Speaker 5: into the cell. It can't get into the cell glue
42:40
Speaker 5: to thione saw its superoxide, dismutaste, and catalase are produced
42:45
Speaker 5: inside the cell. So if you want to boost your
42:50
Speaker 5: glue to thione level in your cell, as long as
42:52
Speaker 5: the mechanism to produce it is still intact, you should
42:56
Speaker 5: be taking lysine leucine, the amino acid that actually build
43:01
Speaker 5: the glue to thione, not taking glue thione directly because
43:06
Speaker 5: glue thiome won't make it past the HCl and your stomach,
43:10
Speaker 5: and even when you put it in the bloodstream from
43:12
Speaker 5: a an arterial or intervenously, the it can't get absorbed
43:21
Speaker 5: through the cell wall. It has to be made intrast cellularly,
43:26
Speaker 5: it has to be inside the cell. But it turns
43:29
Speaker 5: out you've heard of turmeric, curcumin. These are pretty strong antioxidants.
43:37
Speaker 5: And we measure the ability of those antioxidants through a
43:42
Speaker 5: test called an o RAQ score, an oxygen radical absorption coefficient.
43:48
Speaker 5: So dark chocolate, which I like, has an OX score
43:54
Speaker 5: of about twenty thousand. Turmeric has an OX score of
43:58
Speaker 5: one hundred and twenty seven thousand, pretty high on the
44:02
Speaker 5: antioxidant level. One hundred and twenty seven thousand, the last
44:08
Speaker 5: is two point two million. It's the most powerful antioxidant
44:14
Speaker 5: known to exist, and from a commercial point of view,
44:19
Speaker 5: it's readily available. So when we look at the oxygen
44:26
Speaker 5: radical the pre radical absorption coefficient of astes aantin, there's
44:34
Speaker 5: nothing on the planet that can come close. So we
44:38
Speaker 5: know what the effect of this is. And now when
44:41
Speaker 5: the NIH, after I gave my report in April of
44:45
Speaker 5: twenty nineteen, the NIH went out and allocated funding to
44:50
Speaker 5: go ahead and do research. I think to prove me wrong.
44:53
Speaker 5: And that's okay. That's part of the scientific method, is
44:57
Speaker 5: to prove me wrong. Because if they can't prove me wrong,
45:00
Speaker 5: and then there obviously is something true about it. So
45:03
Speaker 5: I understood that I actually volunteered to help them, and
45:06
Speaker 5: they told me that I needed to go away. It
45:09
Speaker 5: need to be independent, and I understood that too. So
45:13
Speaker 5: what happened was several months later, I begin to see
45:20
Speaker 5: these research papers come out of the NIH in direct
45:24
Speaker 5: support of everything that I had found. That was the
45:28
Speaker 5: most remarkable moment of my entire life. And I now
45:34
Speaker 5: know what my purpose was, why I didn't die back
45:39
Speaker 5: in two thousand and six. And now everyone, I don't
45:45
Speaker 5: have to be here to tell this story anymore. All
45:49
Speaker 5: you have to do is Google or search as does
45:52
Speaker 5: Anton and NIH for the National Institute of Health and
46:00
Speaker 5: whatever disease you want to look at, arthritis, cancer, type two, diabetes, Parkinson's,
46:08
Speaker 5: and all of the research shows the impact of the
46:12
Speaker 5: astas anthon on those days.
46:14
Speaker 6: All right, dear listeners, we're going to pause the episode
46:19
Speaker 6: right here, and we're going to be back in two
46:22
Speaker 6: weeks with the rest of the episode with doctor Samuel Shepherd,
46:26
Speaker 6: So stay tuned. We have a lot more fun insights
46:31
Speaker 6: in store for you in the next episode.
46:34
Speaker 2: Thank you for tuning in to another episode of the
46:37
Speaker 2: Holistic Pharmacy Podcast, and I truly hope you enjoyed the show.
46:41
Speaker 2: If you learn something useful in this episode, please consider
46:45
Speaker 2: giving the show a five star rating and a sincere
46:48
Speaker 2: review so that more people can find it or share
46:51
Speaker 2: it with a friend directly. To get in touch with me,
46:54
Speaker 2: you can find me on social media by looking up
46:56
Speaker 2: my name Marina books Of, or email me at Marina
47:01
Speaker 2: at rawfork dot com. Take good care and see you soon.